The antiserum was produced against synthesized peptide derived from human NF-kappaB p65 around the phosphorylation site of Ser311.
Immunogen Range
278-327
Clonality
Polyclonal
Application Dilutions
WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:40000
Specificity
NF-kappaB p65 (Phospho-Ser311) Antibody detects endogenous levels of NF-kappaB p65 only when phosphorylated at Ser311.
Purification
The antibody was purified from rabbit antiserum by affinity-chromatography using phospho peptide. The antibody against non-phospho peptide was removed by chromatography using corresponding non-phospho peptide.
Physical Form
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Storage/Stability
Stable at -20°C for at least 1 year.
NCBI Gene Symbol
RELA
Database Links
Gene ID: 5970 Swiss-Prot #: Q04206
OMIM #: 164014 Unigene #: Hs.502875
Target Modification
Phospho
Modification Sites
H:S311 M:S311
Application Images
Image 1
Immunohistochemistry analysis of paraffin-embedded human breast carcinoma, using NF-kappaB p65 (Phospho-Ser311) Antibody. The picture on the right is blocked with the phospho peptide.
Image 2
Western blot analysis of lysates from LOVO cells treated, using NF-kappaB p65 (Phospho-Ser311) Antibody. The lane on the right is blocked with the phospho peptide.